The Year in Cardio-oncology 2022

被引：8

作者：

Ahmed, Talha ^{[1
,2
]}

Marmagkiolis, Konstantinos ^{[2
]}

Ploch, Michelle ^{[1
]}

Irizarry-Caro, Jorge A. ^{[1
]}

Amatullah, Atia ^{[1
]}

Desai, Shyam ^{[1
]}

Aziz, Moez K. ^{[1
,2
]}

Yarrabothula, Akshitha ^{[1
]}

Fossas-Espinosa, Jose ^{[1
]}

Koutroumpakis, Efstratios ^{[2
]}

Hassan, Saamir ^{[2
]}

Karimzad, Kaveh ^{[2
]}

Kim, Peter ^{[2
]}

Cilingiroglu, Mehmet ^{[2
]}

Iliescu, Cezar ^{[2
]}

机构：

[1] Univ Texas Hlth Sci Ctr Houston, Div Cardiovasc Med, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Div Cardiovasc Med, Houston, TX 77030 USA

来源：

CURRENT PROBLEMS IN CARDIOLOGY | 2023年 / 48卷 / 01期

关键词：

IMMUNE CHECKPOINT INHIBITORS; PERCUTANEOUS CORONARY INTERVENTION; BREAST-CANCER; MAGNETIC-RESONANCE; CARDIOTOXICITY; RISK; MYOCARDITIS; INFARCTION; EVENTS;

D O I：

10.1016/j.cpcardiol.2022.101435

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular disease and cancer are the leading causes of death worldwide. With advent of novel and improved cancer therapies, a growing population of cancer patients with cardiac complications is seen. Taking this into consideration, the clinical studies have also shifted their focus from the study of a single disease to the interdisciplinary study of oncology and cardiology. This current review article provides a comprehensive review of all major articles and guidelines from the year 2021-2022 in the field of cardio-oncology. (Curr Probl Cardiol 2023;48:101435.)

引用

收藏

页数：15

相关论文

共 51 条

[1] Cancer treatment resumption in patients with new-generation drug-eluting stents [J].

Balanescu, Dinu Valentin ;

Aziz, Moez Karim ;

Donisan, Teodora ;

Palaskas, Nicolas ;

Lopez-Mattei, Juan ;

Hassan, Saamir ;

Kim, Peter ;

Song, Juhee ;

Ntim, William ;

Cilingiroglu, Mehmet ;

Marmagkiolis, Konstantinos ;

Iliescu, Cezar .

CORONARY ARTERY DISEASE, 2021, 32 (04) :295-301

[2] Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience [J].

Batra, Akshee ;

Patel, Brijesh ;

Addison, Daniel ;

Baldassarre, Lauren A. ;

Desai, Nihar ;

Weintraub, Neal ;

Deswal, Anita ;

Hussain, Zeeshan ;

Brown, Sherry-Ann ;

Ganatra, Sarju ;

Agarwala, Vivek ;

Parikh, Purvish M. ;

Fradley, Michael ;

Ghosh, Arjun ;

Guha, Avirup .

OPEN HEART, 2021, 8 (02)

[3] Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysis [J].

Bishnoi, Rohit ;

Xie, Zhigang ;

Shah, Chintan ;

Bian, Jiang ;

Murthy, Hemant S. ;

Wingard, John R. ;

Farhadfar, Nosha .

CANCER MEDICINE, 2021, 10 (01) :70-78

[4] Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2-Targeted Breast Cancer Therapy [J].

Bonsignore, Alis ;

Marwick, Thomas H. ;

Adams, Scott C. ;

Thampinathan, Babitha ;

Somerset, Emily ;

Amir, Eitan ;

Walker, Mike ;

Abdel-Qadir, Husam ;

Koch, C. Anne ;

Ross, Heather J. ;

Woo, Anna ;

Wintersperger, Bernd J. ;

Haykowsky, Mark J. ;

Thavendiranathan, Paaladinesh .

JACC: CARDIOONCOLOGY, 2021, 3 (05) :678-691

[5] 2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab [J].

Bouwer, Nathalie, I ;

Liesting, Crista ;

Kofflard, Marcel J. M. ;

Brugts, Jasper J. ;

Kock, Marc C. J. ;

Kitzen, Jos J. E. M. ;

Levin, Mark-David ;

Boersma, Eric .

CARDIOVASCULAR ULTRASOUND, 2021, 19 (01)

[6] Arterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature [J].

Cheng, Connie ;

Nguyen, Michelle Nadeau ;

Nayernama, Afrouz ;

Jones, S. Christopher ;

Brave, Michael ;

Agrawal, Sundeep ;

Amiri-Kordestani, Laleh ;

Woronow, Daniel .

VASCULAR MEDICINE, 2021, 26 (05) :526-534

[7] Real-time exercise reduces impaired cardiac function in breast cancer patients undergoing chemotherapy: A randomized controlled trial [J].

Chung, Wei-Pang ;

Yang, Hsin-Lun ;

Hsu, Ya-Ting ;

Hung, Ching-Hsia ;

Liu, Ping-Yen ;

Liu, Yen-Wen ;

Chan, Shih-Hung ;

Tsai, Kun-Ling .

ANNALS OF PHYSICAL AND REHABILITATION MEDICINE, 2022, 65 (02)

[8] The risk of cardiac events in patients receiving immune checkpoint inhibitors a nationwide Danish study [J].

D'Souza, Maria ;

Nielsen, Dorte ;

Svane, Inge Marie ;

Iversen, Kasper ;

Rasmussen, Peter Vibe ;

Madelaire, Christian ;

Fosbol, Emil ;

Kober, Lars ;

Gustafsson, Finn ;

Andersson, Charlotte ;

Gislason, Gunnar ;

Torp-Pedersen, Christian ;

Schou, Morten .

EUROPEAN HEART JOURNAL, 2021, 42 (16) :1621-1631

[9] Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis [J].

Dolladille, Charles ;

Akroun, Julia ;

Morice, Pierre-Marie ;

Dompmartin, Anne ;

Ezine, Emilien ;

Sassier, Marion ;

Da-Silva, Angelique ;

Plane, Anne-Flore ;

Legallois, Damien ;

L'orphelin, Jean-Mathieu ;

Alexandre, Joachim .

EUROPEAN HEART JOURNAL, 2021, 42 (48) :4964-+

[10] Myocardial Ischemia Induced by5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study [J].

Dyhl-Polk, Anne ;

Schou, Morten ;

Vistisen, Kirsten K. ;

Sillesen, Anne-Sophie ;

Serup-Hansen, Eva ;

Faber, Jens ;

Klausen, Tobias W. ;

Bojesen, Stig E. ;

Vaage-Nilsen, Merete ;

Nielsen, Dorte L. .

ONCOLOGIST, 2021, 26 (03) :E403-E413

← 1 2 3 4 5 6 →